Herpes Zoster Ophthalmicus: Shingles of the Eye
What Is Herpes Zoster Ophthalmicus?
HZO is caused by the same virus that causes chickenpox. Once you have had chickenpox, that virus stays in your nervous system for life, and under the right conditions it can become active again. Understanding what triggers it and who is at risk helps explain why early attention matters so much.
The varicella-zoster virus (the virus behind chickenpox) stays dormant, or sleeping, in nerve tissue after a chickenpox infection. When it reactivates, it travels along a specific branch of the trigeminal nerve that supplies the forehead, upper eyelid, and nose. Because this same nerve connects to the eye, the virus can reach the front and, in rare cases, the back of the eye as well.
The immune system normally keeps the dormant virus in check. As people age, that immune control can gradually weaken. Stress, other illnesses, and medications that suppress the immune system (such as those used after organ transplants or for autoimmune conditions) can also trigger reactivation. When the virus wakes up, it travels back down the nerve toward the skin and the eye.
HZO accounts for roughly 10 to 20 percent of all shingles cases. The general lifetime risk of shingles is approximately 1 in 3. Risk rises sharply after age 50 as natural immune function declines. People taking immune-suppressing medications are also at higher risk regardless of age.
HZO is not just a skin rash. The virus can inflame the cornea (the clear dome at the front of the eye), the iris (the colored part of the eye), the eye's drainage system, and even the retina at the back of the eye. Starting antiviral treatment early shortens the active phase of illness and lowers the risk of lasting damage to the eye and its nerves.
Signs and Symptoms
HZO follows a recognizable pattern, though symptoms can vary from person to person. Knowing what to look for, especially in the early stages, gives you the best chance of getting care within the critical treatment window.
Before any rash appears, many people feel burning, tingling, or sharp pain on one side of the forehead or around the eye. The skin in that area may become very sensitive to touch. Headache, low-grade fever, and fatigue can accompany these early sensations. This phase often looks like a simple headache or minor viral illness, which is why it can be easy to miss.
Within a few days, red patches appear and quickly turn into clusters of small blisters. The rash follows one side of the forehead, upper eyelid, and nose. It stops at the midline of the face and rarely crosses to the other side. Over the following week or so, the blisters crust over and begin to heal.
When blisters appear on the tip or side of the nose, this is called Hutchinson sign. It matters because the small nerve branch that serves the nose also connects to important structures inside the eye. Hutchinson sign is a strong warning that the eye itself may be involved, and anyone who develops it needs a prompt eye exam right away.
When the eye is involved, you may notice redness, tearing, blurred vision, light sensitivity, or a gritty feeling. The eyelid can swell and become difficult to open. In more serious cases, the cornea may become cloudy. Eye symptoms can appear at the same time as the rash or develop weeks later, so staying alert after the rash is important.
A meaningful portion of HZO patients go on to develop postherpetic neuralgia, which is burning or stabbing nerve pain that lasts longer than 90 days after the rash first appeared. Older age is the strongest predictor of this complication. The pain can disrupt sleep, mood, and daily functioning, and it often requires care that goes beyond standard eye treatment.
Eye Conditions HZO Can Cause
HZO can affect nearly every structure of the eye. Some problems appear during the active rash phase, while others develop weeks or months later. Knowing these conditions helps explain why ongoing follow-up care is just as important as treatment during the initial outbreak.
The eyelid margin often becomes inflamed, a condition called blepharitis. Blisters on the lid can scar the lid margin as they heal. The clear lining of the eye (the conjunctiva) can also become red and irritated, a condition called conjunctivitis. These problems often improve as the rash heals but may require lubricating drops and regular lid care for several weeks.
The cornea is the clear dome at the very front of the eye. HZO can cause several forms of corneal inflammation. Early in the illness, small branching sores may form on the corneal surface. Later, deeper inflammation can produce cloudy patches within the corneal tissue itself. A slower form of inflammation called disciform keratitis can appear weeks or even months after the rash seems to have cleared.
HZO can damage the tiny nerves that supply the cornea. When corneal nerves are weakened, the eye loses its ability to sense dryness, irritation, or minor injury. This is called neurotrophic keratopathy. Without that sensation, the surface of the cornea can break down without obvious warning. Neurotrophic problems can appear long after the rash and require careful, ongoing management.
Inflammation inside the front chamber of the eye is called anterior uveitis or iritis. It causes aching pain, redness, and sensitivity to light. HZO can also inflame the drainage system of the eye, causing eye pressure to rise. Elevated pressure that goes untreated can threaten the optic nerve, so pressure monitoring is a standard part of HZO eye care.
In rare but serious cases, the virus can reach the back of the eye. Acute retinal necrosis is a severe form of retinal inflammation that can cause sudden blurring, floaters, and rapid vision loss. HZO can also weaken the muscles that control eye movement, resulting in double vision. These complications are uncommon but require urgent evaluation when they occur.
How HZO Is Diagnosed
Most cases of HZO can be identified through a careful clinical exam. In some situations, additional testing provides important detail that guides treatment decisions. A thorough evaluation covers every structure that HZO is known to affect.
The diagnosis is usually made by examining the rash and performing a detailed eye exam. The rash pattern, which follows one side of the forehead, upper lid, and nose along the V1 nerve branch, is a strong identifying feature. The eye exam assesses the lids, corneal surface, iris, eye pressure, and the back of the eye.
Lab tests are not needed in typical presentations. When the rash is mild, unusual, or absent, PCR testing of blister fluid or corneal scrapings can confirm the diagnosis. Testing is also useful when deeper eye inflammation has an unclear cause and the clinical picture is uncertain.
Your eye care provider may check how well your cornea responds to light touch. A reduced response signals nerve damage and raises the risk of neurotrophic disease, where the eye surface can break down without warning. People with weakened corneal sensation need closer monitoring and more consistent use of lubricating drops.
Eye pressure is measured at every visit because HZO can raise it without causing obvious symptoms. Elevated pressure can quietly damage the optic nerve over time. Regular pressure checks during and after an HZO episode are essential. Some patients need pressure-lowering drops for weeks or months until the inflammation resolves.
A dilated exam of the back of the eye checks for uncommon but serious complications such as retinal inflammation. Any sudden drop in vision, new floaters, or flashes of light in someone who has or recently had HZO is treated as an emergency and warrants same-day evaluation.
Treatment Options
Treatment for HZO addresses the virus itself, the inflammation it causes in various eye structures, and the nerve pain that can follow. The right combination of treatments depends on which parts of the eye are involved and how severe the condition is.
Oral antiviral pills are the foundation of HZO treatment. Common options include acyclovir, valacyclovir, or famciclovir, each taken for approximately 7 days. Starting antiviral treatment within 72 hours of rash onset shortens the active phase, reduces the risk of eye complications, and lowers the likelihood of long-term nerve pain. Beginning treatment promptly is one of the most important steps you can take.
Topical steroid drops are used to treat corneal inflammation, iritis, and immune-related eye disease. A gradual taper over several weeks is common to avoid rebound inflammation. Topical antiviral drops or gel may be added in selected cases of surface viral disease. Lubricating drops and, when needed, a bandage contact lens help protect the corneal surface as it heals.
When HZO raises eye pressure, pressure-lowering drops are started and continued until pressure returns to normal. For most patients, the pressure rise is temporary and drops can be tapered off with time. Some patients require longer treatment, which is why regular follow-up with pressure monitoring is essential throughout recovery.
Long-term nerve pain after HZO does not always respond to standard pain relievers. Oral medications specifically used for nerve pain, such as gabapentin or certain older antidepressants, often provide meaningful relief. Topical patches containing lidocaine or capsaicin can offer additional comfort. When pain is severe or persistent, care from a pain specialist alongside eye care gives the best outcome.
Some patients experience repeated flares of HZO-related corneal disease or iritis over time. Research from a large clinical trial called the Zoster Eye Disease Study supports the use of daily low-dose valacyclovir to reduce the rate of these recurrences in people with a history of HZO eye disease. Your eye care provider can review whether this approach is appropriate for your situation.
When corneal damage is severe or long-standing, additional interventions may be needed. A bandage contact lens can protect a fragile corneal surface. Amniotic membrane grafts can help persistent surface wounds heal. In cases where significant scarring blocks vision, a corneal transplant may be considered. These steps are reserved for the most serious cases and are typically pursued after the active virus is well controlled.
Prevention and the Shingles Vaccine
Vaccination is currently the most effective way to prevent shingles and its eye complications. Combined with healthy habits that support immune function, vaccination offers meaningful protection for adults at risk.
The recombinant shingles vaccine is the primary tool recommended to prevent HZO. The CDC recommends it for all adults age 50 and older, and for adults age 19 and older who have a weakened immune system. The vaccine is given in two doses separated by two to six months. In the early years following vaccination, reported effectiveness against shingles and postherpetic neuralgia is approximately 90 percent.
Vaccination lowers the chance of ever developing HZO. If shingles does occur after vaccination, cases tend to be milder, which translates to a lower risk of corneal scarring, iritis, and lasting nerve pain. For older adults and those with conditions that weaken the immune system, the vaccine is one of the clearest steps available to protect long-term eye health.
General immune health supports the body's ability to keep the dormant virus in check. Consistent sleep, balanced nutrition, and steady management of ongoing medical conditions all contribute. People taking immune-suppressing medications should discuss vaccine timing with both their primary care provider and their specialist before getting the shingles vaccine.
HZO does not spread to other people as shingles. However, the fluid inside fresh blisters contains live virus, which can transmit chickenpox to someone who has never been infected or vaccinated. Keep blisters covered while they are active and avoid close contact with newborns, pregnant people without prior chickenpox immunity, and anyone with a weakened immune system until the rash has fully crusted over.
Outlook and Long-Term Care
With prompt treatment, most people with HZO recover well and maintain good vision. Still, the condition can have lasting effects that require ongoing eye care. Knowing what to expect helps you stay ahead of complications.
The skin rash usually crusts over within one to two weeks. Active pain and viral inflammation generally settle within a few weeks. Eye complications, however, can emerge or resurface weeks to months after the rash appears to have healed. This is why follow-up eye appointments continue well beyond the initial phase of illness.
Most people who receive early antiviral treatment return to their baseline vision. Some individuals experience lasting corneal scarring, reduced corneal nerve sensitivity, or recurrent iritis that affects vision over time. Consistent eye care and diligent surface protection can limit these effects. A small number of patients ultimately require procedures or corneal transplant surgery to restore functional vision.
Seek care the same day if you notice a new blistering rash on one side of the forehead, eyelid, or nose, especially alongside eye pain, redness, blurred vision, or light sensitivity. Antiviral treatment is most effective when started within 72 hours of rash onset. Also seek urgent evaluation for sudden vision loss, new floaters, or severe eye pain during or after an HZO episode.
People with a history of HZO benefit from regular eye exams for several months after the rash clears. These visits check the cornea, iris, and eye pressure, and look for signs of nerve damage or late-onset inflammation. Patients with prior HZO eye disease may need annual monitoring for years, since complications can recur long after the initial episode.
Frequently Asked Questions
These answers address common questions about living with and managing HZO that go beyond the core information covered above.
Whether driving is safe depends on how much your vision and comfort are affected. If you are experiencing significant blurring, severe light sensitivity, or eye pain that limits your ability to focus, it is not safe to drive. Many people take time away from driving during the most intense phase of the illness. Your eye care provider can give you a clear recommendation based on what your exam shows.
A full recurrence of the HZO rash in the same area is possible but less common than a first episode. What happens more frequently is that the underlying eye inflammation, such as corneal disease or iritis, flares up months or years after the original episode. These later flares can occur with minimal warning, which is one of the key reasons that long-term follow-up eye care is so important even when you feel well.
Yes, a past episode of shingles or HZO does not provide reliable protection against a future episode. The CDC recommends receiving the recombinant shingles vaccine once you have fully recovered from the acute illness, typically after the rash and pain have resolved. Timing the vaccine correctly is important, so discuss it with your primary care provider when you are ready.
Most patients complete a standard 7-day course at the beginning of the illness and do not need ongoing antiviral medication. However, patients who experience repeated flares of corneal inflammation or iritis linked to prior HZO may benefit from low-dose daily antiviral therapy. This is not a decision to make independently. Your eye care provider can weigh the evidence from clinical research against your specific history and help you decide.
Wait until the rash has fully crusted over and the skin has completely healed before applying any makeup near the affected area. Starting too soon can irritate already sensitive skin and increase the risk of secondary infection. When you do resume, use fresh products and clean application tools to avoid reintroducing bacteria to skin that is still recovering.
Mild pigment changes or small scars where blisters were present are possible, particularly after a severe rash. Starting antiviral treatment promptly and avoiding picking or scratching blisters reduces the risk of significant scarring. If skin changes persist after the rash has healed, a dermatologist can advise on appropriate skin care and treatment options.
See Our Team for Expert HZO Care in Cheshire
If you are experiencing a rash near your eye, eye pain, or any sudden change in vision, we encourage you to contact ReFocus Eye Health Cheshire as soon as possible. Our team is experienced in evaluating and managing HZO at every stage, from the first signs of a rash through long-term recovery. We provide the thorough, timely care this condition requires, and we are here to help protect your vision and your overall eye health.
Refocus is an excellent Ophthalmologist. Timely, gentle, thorough and friendly. Recommend highly
Carol M
Everyone in the Cheshire office is so friendly and professional. Very pleasant experience being seen in this office.
Gerri Gigi
I was very satisfied with my visit at Refocus Eye Health today - I definitely will be coming back!
Cornelia Voils
DR.PAUL MASI, JUST GREAT AND CARING. THANK YOU ALL FOR TIME AND SERVICE. GOD BLESS!
Deborah Wojick
As a new patient I found Dr. Oropesa to be very attentive to my needs and would highly recommend
Virginia Chirsky
Contact Us
Tuesday: Array
Wednesday: Array
Thursday: Array
Friday: Array
Saturday: Array
Sunday: Array